Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development Portfolio News / By admin July 17, 2019
REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers Portfolio News / By admin July 9, 2019
ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer Portfolio News / By admin July 9, 2019
